Table 1.
The expression, function and mechanism of lncRNAs in EC.
| LncRNA | Expression | Function | Mechanism | Ref. |
|---|---|---|---|---|
| CASC2 | Downregulation | — | — | [19] |
| GAS5 | Downregulation | Tumor suppressor | Induced PTEN expression via inhibiting miR-103 | [20] |
| MEG3 | Downregulation | Tumor suppressor | Combined directly with PI3K protein and reduced its expression | [21,22] |
| FER1L4 | Downregulation | Tumor suppressor | Enhanced PTEN expression | [23,24] |
| LINC00672 | Downregulation | Tumor suppressor | Served as a locus-restricted cofactor for p53-mediated gene suppression | [25] |
| CCAT2 | Upregulation | Oncogene | Activated the PI3K/AKT pathway by reducing miR-216b expression | [26] |
| BANCR | Upregulation | Oncogene | Activated the MEK/ERK signaling | [27] |
| NEAT1 | Upregulation | Oncogene | Activated the WNT/β-catenin pathway via inhibiting miR-146b and miR-214 expression | [28] |
| MALAT1 | Upregulation | Oncogene | Inhibited miR-200c expression | [29] |
| H19 | Upregulation | Oncogene | Induced EMT via inhibiting let-7 expression | [30,31,32,33,34,35] |
| HOTAIR | Upregulation | Oncogene | Increased NPM1 expression via suppressing miR-646 expression | [36,37,38,39] |
| UCA1 | Upregulation | Oncogene | — | [40] |
| CARLo-5 | Upregulation | — | — | [41] |
| TDRG1 | Upregulation | Oncogene | Directly interacted with VEGF-A protein and upregulated its expression | [42] |
| TUG1 | Upregulation | Oncogene | Increased VEGF-A expression via suppressing miR-34a and miR-299 | [43] |
| PCGEM1 | Upregulation | Oncogene | Activated the STAT3 pathway via reducing miR-129 expression | [44] |